跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
邱 弘毅
教授
,
公共衛生學系
合聘教授
,
醫務管理學系
合聘教授
,
高齡健康暨長期照護學系
合聘教授
,
臨床醫學研究所
合聘教授
,
醫學人文研究所
合聘教授
,
應用流行病學碩士學位學程
合聘教授
,
全球衛生暨衛生安全碩士學位學程
合聘教授
,
全球衛生暨衛生安全博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
合聘教授
,
神經醫學博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
成員
,
臺北醫學大學神經醫學研究中心
https://orcid.org/0000-0002-4545-9697
電子郵件
hychiou
tmu.edu
tw
No. 250 Wu-Xing Street, Taipei 11031
h-index
10927
引文
47
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1994 …
2025
每年研究成果
概覽
指紋
網路
專案
(110)
研究成果
(332)
資料集
(9)
類似的個人檔案
(6)
指紋
查看啟用 Hung-Yi Chiou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
80%
Well Water
77%
Malignant Neoplasm
71%
Brain Ischemia
56%
Cigarette Smoking
55%
Disease
50%
Carotid Atherosclerosis
50%
Dose-Response Relationship
49%
Chronic Kidney Failure
45%
Transitional Cell Carcinoma
42%
Bladder Cancer
41%
Lung Cancer
36%
Ischemic Heart Disease
29%
Diabetes Mellitus
28%
Blackfoot Disease
28%
Prevalence
26%
Long Term Exposure
24%
Cardiovascular Disease
23%
Chemotherapy
22%
Glutathione
21%
Transferase
20%
Injury
19%
Non Insulin Dependent Diabetes Mellitus
19%
Atherosclerosis
18%
Methanearsonic Acid
18%
Cerebrovascular Disease
17%
Ethanol
17%
Comorbidity
17%
Case-Control Study
16%
Overall Survival
16%
Breast Cancer
16%
Urinary Tract Cancer
15%
Deterioration
14%
Cisplatin
14%
Fluorouracil
14%
Advanced Glycation End Product Receptor
14%
Heme Oxygenase 1
14%
Rheumatoid Arthritis
14%
Bevacizumab
14%
Colorectal Cancer
14%
Infection
13%
Cancer Registry
13%
Arginine
12%
Biological Marker
11%
Intestine Cancer
11%
Cacodylic Acid
11%
Cancer Incidence
11%
Neoplasm
10%
Brain Hemorrhage
10%
Skin Cancer
10%
Medicine and Dentistry
Apoplexy
100%
Cohort Analysis
77%
Brain Ischemia
74%
Diabetes
37%
Odds Ratio
36%
Malignant Neoplasm
36%
Disease
33%
Cigarette Smoking
29%
Carotid Atherosclerosis
28%
Chronic Kidney Disease
28%
Well Water
26%
Hazard Ratio
25%
Diabetes Mellitus
23%
Transitional Cell Carcinoma
23%
Prevalence
22%
Bladder Cancer
22%
Blackfoot Disease
22%
Ischemic Heart Disease
21%
Urinary System
21%
Dose Response
21%
Case-Control Study
20%
Injury
19%
Breast Cancer
18%
COVID-19
18%
Cerebral Hemorrhage
17%
Methylation
17%
Lung Cancer
16%
Proportional Hazards Model
16%
Anemia
15%
Body Mass Index
15%
Hyperglycemia
15%
Infection
15%
Geriatrics
14%
Systematic Review
14%
Advanced Glycation End Product Receptor
14%
Hemoglobin A1c
13%
Logistic Regression Analysis
13%
Adolescent
12%
Cancer Risk
12%
Maturity Onset Diabetes of the Young
12%
Smoking
12%
Study Subject
11%
Traumatic Brain Injury
11%
Intestine Cancer
11%
Survival Rate
10%
Drug Therapy
10%
Genetic Polymorphism
10%
Kidney Function
10%
Bladder
10%
Gene Linkage
10%
Nursing and Health Professions
Confidence Interval
56%
Odds Ratio
40%
Cohort Analysis
37%
Adolescent
23%
Prevalence
23%
Disease
22%
Injury
22%
Traumatic Brain Injury
22%
Cigarette Filter
21%
Brain Ischemia
14%
Subacute Care
14%
Breast Cancer
14%
National Health Insurance
13%
Blood Pressure
13%
Mortality Rate
11%
Chronic Kidney Failure
11%
World Health Organization
11%
Tobacco Control
10%
Severe Acute Respiratory Syndrome
10%
Long Term Care
10%
Outpatient
10%
Independent Practice Association
10%
Hospital
10%
Comorbidity
9%
Disability
9%
Health Care Planning
9%
Psychiatrist
9%
Malpractice
9%
Total Quality Management
9%
Health Service
9%
Infrared Photography
9%
Lung Cancer
9%
Insulin Resistance
9%
Hypogonadism
9%
Clinical Outcome
9%
Human Immunodeficiency Virus
9%
Rehabilitation Engineering
8%
Head Injury
8%
Cardiovascular Disease
8%
Teaching Hospital
8%
Survival Rate
8%
Waist Circumference
8%
Chronic Disease
7%
Body Mass
7%
Infection Control
7%
Liver Cirrhosis
7%
Internal Consistency
7%
Alanine Aminotransferase
7%
Tuberculosis
6%
Propensity Score
6%
